Omnicell
OMCL
385 hedge funds and large institutions have $5.42B invested in Omnicell in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 155 increasing their positions, 131 reducing their positions, and 46 closing their positions.
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
24% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $8.37M
18% more repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 131
3.73% more ownership
Funds ownership: 104.06% → 107.79% (+3.7%)
7% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 46
3% less funds holding
Funds holding: 396 → 385 (-11)
9% less capital invested
Capital invested by funds: $5.98B → $5.42B (-$565M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$92.7M |
| 2 |
Swedbank
Stockholm,
Sweden
|
+$33.2M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$15.5M |
| 4 |
Bank of New York Mellon
New York
|
+$13.5M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$13.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$47.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$18.9M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$15.9M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$9.49M |
| 5 |
BSCM
Berry Street Capital Management
London,
United Kingdom
|
-$8.09M |
OMCL Hedge Fund Activity: Q2 2022 in Review
385 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2022, worth a combined $5.42B — down 9.4% from $5.98B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of OMCL and 43 opened new positions — a net loss of 3 holders — while 131 trimmed existing stakes and 155 added.
The largest buyer was Lazard Asset Management, adding an estimated $92.7M. The largest seller was Jackson Square Partners, exiting entirely with an estimated $47.9M sold.
- 385 institutional investors held Omnicell (OMCL) as of Q2 2022, down from 396 in Q1 2022.
- Funds reported $5.42B of Omnicell stock for Q2 2022, down 9.4% quarter-over-quarter.
- 43 funds opened new Omnicell positions in Q2 2022 and 46 closed out, a net change of -3 holders.
- The largest Omnicell buyer in Q2 2022 was Lazard Asset Management, an estimated $92.7M added.
- The largest Omnicell seller in Q2 2022 was Jackson Square Partners, an estimated $47.9M sold.
Based on aggregated 13F filings for Q2 2022.